These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19106589)

  • 21. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential susceptibility to apoptosis of CD4+T cells expressing CCR5 and CXCR3 in patients with MS.
    Julià E; Edo MC; Horga A; Montalban X; Comabella M
    Clin Immunol; 2009 Dec; 133(3):364-74. PubMed ID: 19740704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation.
    Perros F; Hoogsteden HC; Coyle AJ; Lambrecht BN; Hammad H
    Allergy; 2009 Jul; 64(7):995-1002. PubMed ID: 19630858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Th1 and Th2 responses on the ocular surface in uveitis identified by CCR4 and CCR5 conjunctival expression.
    Ahn JK
    Am J Ophthalmol; 2008 Feb; 145(2):387; author reply 387-8. PubMed ID: 18222196
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant human granulocyte colony-stimulating factor significantly decreases the expression of CXCR3 and CCR6 on T cells and preferentially induces T helper cells to a T helper 17 phenotype in peripheral blood harvests.
    Sun LX; Ren HY; Shi YJ; Wang LH; Qiu ZX
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):835-43. PubMed ID: 19539215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Meregalli S; Porro G; Rovelli F; Vigorè L; Tisi E; D'Amico G
    Anticancer Res; 2009 May; 29(5):1847-52. PubMed ID: 19443415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
    Nagamine I; Yamaguchi Y; Ohara M; Ikeda T; Okada M
    Hiroshima J Med Sci; 2009 Mar; 58(1):37-44. PubMed ID: 19400555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-eluting scaffold inhibited in vivo pancreatic tumorigenesis by engaging murine CCR4
    Zhan Q; Shen B; Fang Y; Deng X; Chen H; Jin J; Peng C; Li H
    Colloids Surf B Biointerfaces; 2017 Oct; 158():469-473. PubMed ID: 28732312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
    Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
    COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
    Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
    J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of EORTC QLQ-C30 questionnaire in patients undergoing in-hospital chemotherapy for gastrointestinal cancer in Japan.
    Kato J; Nagahara A; Iijima K; Yoshimura M; Osada T; Yoshizawa T; Watanabe S
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S268-72. PubMed ID: 19120910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemotherapy of gastrointestinal cancer].
    De AMESTI F
    Rev Med Chil; 1969 Oct; 97(10):664-74. PubMed ID: 5396754
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.
    Abbrederis K; Lorenzen S; Rothling N; Ihbe-Heffinger A; Schuster T; Peschel C; Lordick F
    Onkologie; 2009 Feb; 32(1-2):30-4. PubMed ID: 19209016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral CD4+CD8+cells are the activated T cells expressed granzyme B (GrB), Foxp3, interleukin 17 (IL-17), at higher levels in Th1/Th2 cytokines.
    Xie D; Hai B; Xie X; Liu L; Ayello J; Ma X; Zhang J
    Cell Immunol; 2009; 259(2):157-64. PubMed ID: 19616200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
    Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
    J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy in gastrointestinal cancer.
    Rechtschaffen JS
    Proc Rudolf Virchow Med Soc City N Y; 1966; 25():6-11. PubMed ID: 5261203
    [No Abstract]   [Full Text] [Related]  

  • 38. Cancer anemia survey in Division of Medical Oncology at Siriraj Hospital (CAS).
    Ithimakin S; Srimuninnimit V
    J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S110-8. PubMed ID: 19562994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modern Immunotherapy for the Treatment of Advanced Gastrointestinal Cancers.
    Khalil DN; Segal NH
    Oncology (Williston Park); 2016 Jan; 30(1):85-90, 93. PubMed ID: 26791849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.